KEVIN GIANG: Open Payments
NPI 1982202859 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 15 payments from 6 companies in 2025. Trend: 2023 $392 · 2024 $324 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 4 | $115 |
| Bioventus LLC | 4 | $105 |
| Ferring Pharmaceuticals Inc. | 4 | $85 |
| Smith+Nephew, Inc. | 1 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Zimmer Biomet Holdings, Inc. | 1 | $16 |
Products named: EXOGEN ULTRASOUND BONE HEALING SYSTEM, EUFLEXXA, ASNIS, VARIAX, PANGEA, GAMMA, Iovera, Gel-One Cross-linked Hyaluronate.
Industry payments across TX — which companies pay providers there.
